Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × tazemetostat × Clear all

NCT07407283 2026-02-12

A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer

Phase 1/2 Not yet recruiting

Prostatic Neoplasms